Report Detail
Global Spine Biologics Market Growth 2019-2024
- RnM2946882 |
- 15 February, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Other
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.
According to this study, over the next five years the Spine Biologics market will register a 3.6% CAGR in terms of revenue, the global market size will reach US$ 2550 million by 2024, from US$ 2060 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Spine Biologics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Spine Biologics market by product type, application, key manufacturers and key regions and countries.
This study considers the Spine Biologics value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Spine Biologics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Spine Biologics market by identifying its various subsegments.
Focuses on the key global Spine Biologics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Spine Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Spine Biologics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Spine Biologics Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Spine Biologics Consumption 2014-2024
- 2.1.2 Spine Biologics Consumption CAGR by Region
- 2.2 Spine Biologics Segment by Type
- 2.2.1 Bone Graft
- 2.2.2 Bone Graft Substitute
- 2.2.3 Platelet Rich Plasma (PRP)
- 2.2.4 BMAC (Bone Marrow Aspirate Concentrate)
- 2.3 Spine Biologics Consumption by Type
- 2.3.1 Global Spine Biologics Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Spine Biologics Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Spine Biologics Sale Price by Type (2014-2019)
- 2.4 Spine Biologics Segment by Application
- 2.4.1 Anterior Cervical Discectomy and Fusion
- 2.4.2 Posterior Lumbar Interbody Fusion
- 2.4.3 Other
- 2.5 Spine Biologics Consumption by Application
- 2.5.1 Global Spine Biologics Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Spine Biologics Value and Market Share by Application (2014-2019)
- 2.5.3 Global Spine Biologics Sale Price by Application (2014-2019)
3 Global Spine Biologics by Players
- 3.1 Global Spine Biologics Sales Market Share by Players
- 3.1.1 Global Spine Biologics Sales by Players (2017-2019)
- 3.1.2 Global Spine Biologics Sales Market Share by Players (2017-2019)
- 3.2 Global Spine Biologics Revenue Market Share by Players
- 3.2.1 Global Spine Biologics Revenue by Players (2017-2019)
- 3.2.2 Global Spine Biologics Revenue Market Share by Players (2017-2019)
- 3.3 Global Spine Biologics Sale Price by Players
- 3.4 Global Spine Biologics Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Spine Biologics Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Spine Biologics Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Spine Biologics by Regions
- 4.1 Spine Biologics by Regions
- 4.1.1 Global Spine Biologics Consumption by Regions
- 4.1.2 Global Spine Biologics Value by Regions
- 4.2 Americas Spine Biologics Consumption Growth
- 4.3 APAC Spine Biologics Consumption Growth
- 4.4 Europe Spine Biologics Consumption Growth
- 4.5 Middle East & Africa Spine Biologics Consumption Growth
5 Americas
- 5.1 Americas Spine Biologics Consumption by Countries
- 5.1.1 Americas Spine Biologics Consumption by Countries (2014-2019)
- 5.1.2 Americas Spine Biologics Value by Countries (2014-2019)
- 5.2 Americas Spine Biologics Consumption by Type
- 5.3 Americas Spine Biologics Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Spine Biologics Consumption by Countries
- 6.1.1 APAC Spine Biologics Consumption by Countries (2014-2019)
- 6.1.2 APAC Spine Biologics Value by Countries (2014-2019)
- 6.2 APAC Spine Biologics Consumption by Type
- 6.3 APAC Spine Biologics Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Spine Biologics by Countries
- 7.1.1 Europe Spine Biologics Consumption by Countries (2014-2019)
- 7.1.2 Europe Spine Biologics Value by Countries (2014-2019)
- 7.2 Europe Spine Biologics Consumption by Type
- 7.3 Europe Spine Biologics Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Spine Biologics by Countries
- 8.1.1 Middle East & Africa Spine Biologics Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Spine Biologics Value by Countries (2014-2019)
- 8.2 Middle East & Africa Spine Biologics Consumption by Type
- 8.3 Middle East & Africa Spine Biologics Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Spine Biologics Distributors
- 10.3 Spine Biologics Customer
11 Global Spine Biologics Market Forecast
- 11.1 Global Spine Biologics Consumption Forecast (2019-2024)
- 11.2 Global Spine Biologics Forecast by Regions
- 11.2.1 Global Spine Biologics Forecast by Regions (2019-2024)
- 11.2.2 Global Spine Biologics Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Spine Biologics Forecast by Type
- 11.8 Global Spine Biologics Forecast by Application
12 Key Players Analysis
- 12.1 Medtronic
- 12.1.1 Company Details
- 12.1.2 Spine Biologics Product Offered
- 12.1.3 Medtronic Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Medtronic News
- 12.2 Depuy Synthes
- 12.2.1 Company Details
- 12.2.2 Spine Biologics Product Offered
- 12.2.3 Depuy Synthes Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Depuy Synthes News
- 12.3 Stryker Corporation
- 12.3.1 Company Details
- 12.3.2 Spine Biologics Product Offered
- 12.3.3 Stryker Corporation Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Stryker Corporation News
- 12.4 Nuvasive
- 12.4.1 Company Details
- 12.4.2 Spine Biologics Product Offered
- 12.4.3 Nuvasive Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Nuvasive News
- 12.5 Zimmer Biomet
- 12.5.1 Company Details
- 12.5.2 Spine Biologics Product Offered
- 12.5.3 Zimmer Biomet Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Zimmer Biomet News
- 12.6 Orthofix International
- 12.6.1 Company Details
- 12.6.2 Spine Biologics Product Offered
- 12.6.3 Orthofix International Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Orthofix International News
- 12.7 Globus Medical
- 12.7.1 Company Details
- 12.7.2 Spine Biologics Product Offered
- 12.7.3 Globus Medical Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Globus Medical News
- 12.8 alphatec spine
- 12.8.1 Company Details
- 12.8.2 Spine Biologics Product Offered
- 12.8.3 alphatec spine Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 alphatec spine News
- 12.9 K2M
- 12.9.1 Company Details
- 12.9.2 Spine Biologics Product Offered
- 12.9.3 K2M Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 K2M News
- 12.10 Exactech
- 12.10.1 Company Details
- 12.10.2 Spine Biologics Product Offered
- 12.10.3 Exactech Spine Biologics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Exactech News
- 12.11 Wright Medical Technology
- 12.12 X-Spine
- 12.13 Nutech
- 12.14 Arthrex
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Spine Biologics . Industry analysis & Market Report on Spine Biologics is a syndicated market report, published as Global Spine Biologics Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Spine Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
